[1] |
WANG Lu, SHAN Jia-jia.
Mechanisms of miRNA promoting invasion and metastasis in ovarian cancer
[J]. Journal of Hebei Medical University, 2023, 44(7): 824-829.
|
[2] |
ZHAO Huan, PANG Yi-cun, ZHAO Jun, XING Hui-min, MA Xiao-lin, HUO Cui-min.
The effect of SPHK1 gene on malignant behavior of epithelial ovarian cancer cells and its related mechanism
[J]. Journal of Hebei Medical University, 2022, 43(11): 1255-1260.
|
[3] |
LIU Yang, KANG Lin, ZHENG Guo-na, ZHAO Huan-fen.
Expression and clinical significance of CRIP1 gene in human ovarian cancer
[J]. Journal of Hebei Medical University, 2021, 42(8): 904-908.
|
[4] |
ZHANG Wei, GUO Bu-qing, HOU Yu-na, WANG Wei-wei, SHANG An-quan.
Analysis of vaginal microecological characteristics and influencing factors in ovarian cancer patients with vaginitis
[J]. Journal of Hebei Medical University, 2021, 42(8): 909-913.
|
[5] |
MENG Tong-yu, ZHAO Tao, SONG Yu-xia, ZHAO Fang, LI Pan, ZHAO Jian.
Expression of miRNA-107 in ovarian cancer tissues and its effect on VEGFA
[J]. Journal of Hebei Medical University, 2021, 42(7): 818-822.
|
[6] |
LI Xia, ZHANG Ke, MIN Nan.
The mechanism of macrophage-derived exosomes inhibiting invasion and migration of epithelial ovarian cancer cells after TWEAK stimulation
[J]. Journal of Hebei Medical University, 2021, 42(2): 163-166.
|
[7] |
REZIYA·Kuerban, GULIMIRE·Buranjiang, GUZALINUER·Abulizi*.
Mechanism of HOST2 lncRNA targeting miR-211 in ovarian cancer cell metastasis#br#
[J]. Journal of Hebei Medical University, 2020, 41(9): 1058-1064.
|
[8] |
MU Wei-hong, CHEN Wen-qi, PENG Yuan-yuan, ZHANG Jing*.
The correlation between the expression of miR-141-3p and Cisplatin chemosensitivity of ovarian cancer cells#br#
[J]. Journal of Hebei Medical University, 2020, 41(2): 167-171.
|
[9] |
ZHANG Long-sheng, LU Yan, ZHANG Kai-hong, YANG Duo, YE Shu-jun, HUANG Zhi-liang.
Comparison of the analgesic effect of quadratus lumborum block and transversus abdominis plane block in gynecological laparoscopic surgery
[J]. Journal of Hebei Medical University, 2020, 41(12): 1450-1454.
|
[10] |
ZUO Hongling1, YAN Xiaonan2, LIU Subin3, LI Xiuwen1, WANG Huilan1, XU Chunlin1, DU Hui1*.
The effects of 17βestradiol on proliferation of ovarian clear cell carcinoma ES2 cell line and the possible mechanism
[J]. Journal of Hebei Medical University, 2019, 40(9): 1029-1033.
|
[11] |
FENG Yanping1, GUO Wei1, LIU Jing2, ZHANG Hongzhen2*, CHENG Jianxin3.
Expression of Wip1 in ovarian serous cystadenocarcinoma tissues and its significance
[J]. Journal of Hebei Medical University, 2018, 38(8): 929-933,937.
|
[12] |
HUANG Ping, LI Yanying, LI Lingling, QI Bingli, SU Mengya, ZHANG Jiyan.
Effects of ATIP3aHMGA2ERK signaling pathway on cisplatin resistance in epithelial ovarian cancer
[J]. Journal of Hebei Medical University, 2018, 38(10): 1179-1184.
|
[13] |
CAO Hua.
Effects of deep hyperthermia combined with systemic chemotherapy on advanced ovarian cancer and its effect on expression of ERCC1, βcatenin and βtubulin Ⅲ#br#
[J]. Journal of Hebei Medical University, 2018, 38(1): 64-67.
|
[14] |
LI Nan1, SUN Yanan2, YANG Liang3, CHEN Suqin1.
Clinical observation of hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with advanced ovarian cancer#br#
[J]. Journal of Hebei Medical University, 2017, 37(12): 1409-1412.
|
[15] |
LI Qi1, ZHAO Junfeng2*, SHI Xiaoyu2, ZHAO Lixia2, LIU Dan1.
Clinical observation of apatinib combined with chemotherapy for secondline treatment failure in advanced ovarian cancer#br#
[J]. Journal of Hebei Medical University, 2017, 37(12): 1384-1387.
|